Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...
The following is a summary of “Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study,” published in the September 2024 issue of ...
Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found ...
The complex and ever-evolving immunity landscape associated with SARS-CoV-2, combined with immune evasion by omicron ...
The following is a summary of “Respiratory viral infections from 2015 to 2022 in the HIVE cohort of American households: Incidence, illness characteristics, and seasonality,” published in the August ...
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of the COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant ...
Seasonal Vaccination Campaign begins on September 20th, offering the safest and most effective measure to prevent Flu and ...
Our study shows the feasibility of real-time estimation of antibody kinetics before SARS-CoV-2 variant emergence. This estimation is valuable for understanding how specific combinations of SARS-CoV-2 ...
Taiwan FDA approves Moderna’s Covid-19 mRNA vaccine targeting the SARS-COV-2 variant JN.1: Cambridge, Massachusetts Wednesday, September 4, 2024, 12:00 Hrs [IST] Moderna, Inc., ...
The new "XEC" COVID-19 variant spreading rapidly in Europe has arrived in the US. What are the symptoms, will it cause a fall ...